SHARE:

< Back to Search

Neurology® Podcast - July 7 2015 Issue

Switching from natalizumab to fingolimod: a randomized, placebo-controlled study of patients with RRMS

1) Switching from natalizumab to fingolimod in patients with remitting-relapsing multiple sclerosis and 2) Topic of the month: Plenary sessions AAN Meeting April 2015. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Ludwig Kappos about his paper on switching from natalizumab to fingolimod in patients with remitting-relapsing multiple sclerosis. Dr. Sarah Wesley is reading our e-Pearl of the week about dopamine-responsive dystonia. In the next part of the podc Read More

Download this Episode

Episode Segments

Introduction (00:17 - 00:50)
00:17 00:50

Play Segment

Interview-Switching from natalizumab to fingolimod: a randomized, placebo-controlled study of patients with RRMS (00:51 - 12:45)
ePearl 1-dopamine-responsive dystonia (12:46 - 14:11)
LOTW-neurologists' burnout, cost and quality of healthcare, value of neurology to congress and payers along with maintenance of certification (14:12 - 34:59)
ePearl 2-dopamine-responsive dystonia (35:00 - 35:48)
Closing (35:49 - 36:26)
35:49 36:26

Play Segment

Log On

MEMBER LOG IN

Forgot password?

**Due to required system maintenance on AAN.com, some functions may be unavailable from 8:00 p.m. to 10:00 p.m. Tuesday (10/17/2017). Thank you for your patience.**